Catalent
CTLT
#1585
Rank
A$16.60 B
Marketcap
$91.48
Share price
-0.17%
Change (1 day)
76.35%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$9.53 Billion

According to Catalent's latest financial reports the company's total liabilities are A$9.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30A$9.31 B11.79%
2022-06-30A$8.33 B29.4%
2021-06-30A$6.43 B3.6%
2020-06-30A$6.21 B12.03%
2019-06-30A$5.54 B19.24%
2018-06-30A$4.65 B30.94%
2017-06-30A$3.55 B8.11%
2016-06-30A$3.28 B0.7%
2015-06-30A$3.26 B-11.22%
2014-06-30A$3.67 B0.01%
2013-06-30A$3.67 B7.89%
2012-06-30A$3.40 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.51 B-94.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.83 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.50 B 31.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$0.49 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA